Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Colorado for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Colorado only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Colorado (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Sara Haug (NPI 1871820837)

Field	Value
Entity Type	Individual
Organization	Sara Haug
Address	1266 Escalante Dr Ste 301
City	Durango
State	CO
ZIP	81303
Taxonomy	Retina Specialist (Ophthalmology) Physician
NPI Enumerated	November 12, 2009

Payer Source	Total Paid
Medicare	$3.9M
Medicaid	$0

Key Findings

SARA HAUG’s Medicare revenue profile is driven overwhelmingly by intravitreal biologic therapy: J2777 (49.4K claims, $29 avg paid/claim, $1.4M revenue, 37.1% of this provider's total Medicare revenue), J0178 (1.8K claims, $688 avg paid/claim, $1.2M revenue, 31.3%), and J2778 (2.3K claims, $174 avg paid/claim, $402.8K revenue, 10.4%). These three medications reflect a practice built around high-volume anti‑VEGF and related retinal injections and together account for the majority of Medicare receipts, consistent with a retina specialist whose primary service line is office-based intravitreal therapy.

The precomputed concentration metric confirms revenue concentration: the top 3 Medicare codes by revenue account for 78.8% of this provider's total Medicare revenue. That level of concentration signals material dependence on a small set of high-revenue drug codes for Medicare earnings and suggests payer or utilization shifts in those products would meaningfully affect overall revenue.

Payer mix is effectively single-payer Medicare: lifetime Medicare revenue is $3.9M while there is no Medicaid billing on file. The absence of Medicaid activity indicates this provider’s outpatient revenue and patient panel—at least in the claims data—operate almost entirely through Medicare rather than a mixed Medicaid/Medicare practice.

Competitive standing varies by product: J2777 ranks #107 of 2039 providers nationally (95th percentile) and is described as notably above typical national volume, indicating a strong national placement for faricimab administration. By contrast, J0178 (rank #662 of 3204, 79th percentile) and J2778 (rank #179 of 1208, 85th percentile) are in respectable but not extreme percentiles and are characterized as typical or unremarkable volumes for those agents, suggesting leadership in one newer agent with routine volumes for others.

Imaging volume is an outlier that supports high clinical throughput: 92134 shows 2.5K claims, $31 avg paid/claim, $78.3K revenue and ranks #650 of 26868 providers nationally (98th percentile; extreme outlier). This unusually high OCT imaging volume aligns with the heavy injection practice and indicates frequent diagnostic monitoring consistent with chronic retinal disease management.

The practice also bills a mix of procedure and surgical codes beyond injections—67028 has 1.9K claims, $104 avg paid/claim, $195.5K revenue (5.1% of Medicare revenue) and the record includes vitrectomy and retinal surgery codes such as 67042 (22 claims, $906 avg paid/claim, $19.9K revenue) and 67036 (22 claims, $687 avg paid/claim, $15.1K revenue). These entries show the provider delivers both office-based therapeutic injections and occasional operative retinal care, indicating a comprehensive retinal service offering rather than purely procedural or purely diagnostic work.

There is a meaningful contribution from unclassified drug billing and implants that may warrant review when modeling payer budgets: J3490 appears with 152 claims, $1753 avg paid/claim, $266.5K revenue (6.9% of Medicare revenue) and J7312 (308 claims, $158 avg paid/claim, $48.7K revenue; 1.3%). The presence of J3490 at this scale highlights that a nontrivial share of drug dollars are routed through unclassified drug codes, which can complicate claim-level cost attribution and forecasting.

The provider has an established billing tenure—NPI enumerated on 2009-11-12 (~17 years ago)—which supports interpretation of these patterns as the output of a sustained retina practice rather than a transient or newly opened clinic. The longevity combined with the high percentile positions for specific codes suggests an experienced retinal specialist with an entrenched clinical workflow focused on frequent imaging and high-volume intravitreal therapy.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

25 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J2777	Injection, faricimab‑svoa, 0.1 mg	49,380	$30	$1.4M
J0178	Injection, aflibercept, 1 mg	1,750	$690	$1.2M
J2778	Injection, ranibizumab, 0.1 mg	2,320	$170	$402.8K
J3490	Unclassified drugs	150	$1,750	$266.5K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	1,880	$100	$195.5K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	2,530	$30	$78.3K
J2781	Injection, pegcetacoplan, intravitreal, 1 mg	560	$120	$66.6K
J7312	Injection, dexamethasone, intravitreal implant, 0.1 mg	310	$160	$48.7K
92014	An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group…	430	$90	$38.1K
92012	For this CPT code, an Ophthalmologist sees an established patient for an intermediate level eye examination. Generally, a patient is considered to be "established" if the same physician, or any…	320	$70	$21.3K

Showing 1–10 of 25

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 25 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Colorado Distribution

Sara Haug — 3 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Colorado

Full comparison — all codes billed, vs. state median

25 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	6	60	740	$690	$618.3K
J2777	2	40	8,910	$30	$456.1K
J2778	3	20	600	$180	$199.7K
J2781	2	10	470	$120	$79.4K
67028	6	80	670	$100	$73.3K
J7312	4	10	220	$160	$37.4K
67036	3	30	20	$1,100	$37.3K
67042	6	30	20	$1,140	$29.6K
67108	2	20	20	$1,260	$26.5K
J3490	4	60	50	$290	$23.1K

Showing 1–10 of 25

Related Providers

Other providers that share a Tax Identification Number (TIN) with Sara Haug, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Roger Goldberg	CA	Retina Specialist (Ophthalmology) Physician	$4.6M	$0
Tuow Ting	CA	Retina Specialist (Ophthalmology) Physician	$2.6M	$0
J Jumper	CA	Retina Specialist (Ophthalmology) Physician	$2.6M	$0
Moss Fenberg	CO	Retina Specialist (Ophthalmology) Physician	$2.3M	$0
Judy Chen	CA	Retina Specialist (Ophthalmology) Physician	$2.2M	$0
Anita Agarwal	CA	Retina Specialist (Ophthalmology) Physician	$2.2M	$0
Robert Johnson	CA	Retina Specialist (Ophthalmology) Physician	$2.1M	$0
Steven Williams	TN	Retina Specialist (Ophthalmology) Physician	$2.1M	$0
H. Mcdonald	CA	Specialist	$1.8M	$0
Caesar Luo	CA	Retina Specialist (Ophthalmology) Physician	$1.8M	$0

Nearby Providers

Other providers in the same ZIP code as Sara Haug, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Community Connections Inc.	CO	Intellectual and/or Developmental Disabilities Community Based Residential Treatment Facility	$0	$21.5M
Southwest Colorado Mental Health Center, Inc	CO	Mental Health Clinic/Center (Including Community Mental Health Center)	$0	$13.5M
Justin Curtis	CO	Podiatrist	$7.7M	$0
Durango Fire Protection District	CO	Land Ambulance	$434.9K	$1.7M
Victoria Knauf	CO	Foot & Ankle Surgery Podiatrist	$1.7M	$0
Kayse Lake	CO	Podiatrist	$1.3M	$790
Grant Gebhard	CO	Ophthalmology Physician	$706.5K	$0
Mark Gaughan	CO	Dermatology Physician	$480.5K	$0
Carmen Julian	CO	Dermatology Physician	$420.6K	$0
Kristin Pogue	CO	Physician Assistant	$191K	$0

Sara Haug — Billing Profile & Reimbursement Data

Sign up for Sara Haug — Billing Profile & Reimbursement Data policy alerts

Sara Haug — Billing Profile & Reimbursement Data

Sign up for Sara Haug — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References